Results 291 to 300 of about 303,149 (361)

Comprehensive Endoscopic Management of Superficial Pharyngeal Cancer – From Detection and Diagnosis to Treatment and Surveillance

DEN Open, Volume 6, Issue 1, April 2026.
Abstract Traditionally, pharyngeal cancer was detected at an advanced stage, as examinations were usually performed only after symptoms such as pain or dysphagia appeared. Consequently, it was considered a malignancy with a poor prognosis. However, recent advances in image‐enhanced endoscopy (IEE) have facilitated the early detection of superficial ...
Daisuke Kikuchi, Yugo Suzuki, Satoshi Yamashita, Yorinari Ochiai, Shu Hoteya   +4 more
wiley   +1 more source

Palliative Care: Symptom Management and end of Life Care [PDF]

, 2007
Ministry of Health and Social Welfare, (MoHSW)
core  

Potential Effectiveness of Yokukansan and Lemborexant as Alternative Candidates to Benzodiazepines to Prevent Benzodiazepine Withdrawal Delirium in the Cancer Perioperative Period: A Case Report and Literature Review

Neuropsychopharmacology Reports, Volume 45, Issue 4, December 2025.
The combination of yokukansan and lemborexant may be an effective replacement for benzodiazepines in terms of 5‐HT, GABA, and sleep cycle. ABSTRACT Background Benzodiazepine withdrawal delirium is a serious problem, and several candidates have been proposed to manage benzodiazepine withdrawal, such as valproic acid and carbamazepine, up to now. However,
Junji Yamaguchi, Ryoichi Sadahiro, Saho Wada, Eri Nishikawa, Tatsuto Terada, Rika Nakahara, Hiromichi Matsuoka   +6 more
wiley   +1 more source

DNA methylation orchestrates secondary metabolite biosynthesis and transport in Papaver somniferum. [PDF]

PLoS One
Aksoylu T, Turktas M.
europepmc   +1 more source

Patient Subgroups and Predictors of Improvement in Chronic Neuropathic Pain: A Trajectory‐Based Analysis

European Journal of Pain, Volume 29, Issue 10, November 2025.
ABSTRACT Background There is limited real‐world evidence on predictive factors for good outcomes in patients with chronic neuropathic pain (NP) treated in multidisciplinary tertiary care centres. This study aimed to identify subgroups of NP patients with similar pain trajectories and evaluate associated factors.
Xavier Moisset, M. Gabrielle Pagé, Bruno Pereira, Manon Choinière   +3 more
wiley   +1 more source

Nalbuphine as a Potential Alternative to Morphine in Sickle Cell Disease Patients with Vaso-occlusive Crisis: A Retrospective Cohort Study. [PDF]

Saudi J Med Med Sci
Alghamdi M, Almulhim M, Almulihi Q, Alhamaid YA, Assiri M, Alzahid A, Al Ghanim B, Albaish L, Alkhunaizi L, Alali S, Alshehri L.   +10 more
europepmc   +1 more source

Efficacy and safety of combining low-dose methadone with ongoing opioid treatment for uncontrolled cancer pain: an open-label single-arm study. [PDF]

Oncologist
Hasegawa T, Okuyama T, Suzuki N, Furukawa Y, Tasaki Y, Iida M, Ito A, Uchida M, Kubota Y, Kikuchi S, Yamakawa H, Harada Y, Akechi T.   +12 more
europepmc   +1 more source

In vitro and in vivo pharmacological characterization of fentanyl analogs. [PDF]

Neuropharmacology
Obeng S, Urquhart KR, Fukuda S, Pallares VLC, McMahon LR, Fantegrossi WE, Hiranita T.   +6 more
europepmc   +1 more source

Antinociceptive effect of Arvelexin in male mouse models. [PDF]

Sci Rep
Bseiso Y, Gammoh O, Qnais E, Barakat M, Oqal M, Abudalo R, Alotaibi BS, Aljabali AAA, Alzaghari LF, Alqudah A.   +9 more
europepmc   +1 more source